CLINICAL RESEARCH: ELECTROPHYSIOLOGIC DISORDERS
The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota
Changes over three decades
Teresa S. M. Tsang, MD, FACC*,*,
George W. Petty, MD ,
Marion E. Barnes, MSc*,
W. Michael O’Fallon, PhD ,
Kent R. Bailey, PhD,
David O. Wiebers, MD ,
JoRean D. Sicks, MS,
Teresa J. H. Christianson, BSc,
James B. Seward, MD, FACC* and
Bernard J. Gersh, MB, ChB, DPhil, FACC*
* Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Division of Cerebrovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
Section of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA
Section of Clinical Epidemiology, Mayo Clinic, Rochester, Minnesota, USA
Manuscript received July 24, 2002;
revised manuscript received November 24, 2002,
accepted December 18, 2002.
* Reprint requests and correspondence: Dr. Teresa S. M. Tsang, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
tsang.teresa{at}mayo.edu
OBJECTIVES: We sought evidence of a change in the prevalence of atrial fibrillation (AF) over a 30-year period among residents of Rochester, Minnesota.
BACKGROUND: Atrial fibrillation is increasingly encountered in clinical practice, but there is limited data on secular trends of AF over time.
METHODS: Within a longitudinal case-control study of ischemic stroke, the prevalence of AF and of selected comorbid conditions among incident stroke cases and age- and gender-matched controls between 1960 and 1989 was determined.
RESULTS: The mean age ± standard deviation for the 1,871 stroke cases (45% men) and matched controls was 75 ± 11 years. For cases, age-adjusted estimates of AF prevalence for 1960 to 1969, 1970 to 1979, and 1980 to 1989 were 11%, 13%, and 16%, respectively, for men, and 13%, 16%, and 20% for women. For controls, the rates were 5%, 8%, and 12%, respectively, for men, and 4%, 6%, and 8% for women. Increasing AF prevalence was associated with increasing age (doubling of odds per decade of age in both cases and controls) and calendar time adjusted for age and gender (cases: odds ratio [OR] per 5 years 1.13, 95% confidence interval [CI], 1.05 to 1.22; controls: OR per 5 years 1.24, 95% CI 1.12 to 1.37). The rates of increase with calendar time were significant for cases (p = 0.001) and controls (p < 0.001) and comparable between the genders.
CONCLUSIONS: The prevalence of AF increased significantly in ischemic stroke patients and their controls from 1960 to 1989 in Rochester, Minnesota, independent of age and gender. The rate of increase did not differ significantly between men and women.
|
Abbreviations and Acronyms
| | AF | | atrial fibrillation | | CI | | confidence interval | | ECG | | electrocardiogram/electrocardiographic | | OR | | odds ratio |
|
This article has been cited by other articles:
|
|
|
|
 
G. A. Nichols, K. Reinier, and S. S. Chugh
Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Diabetes Care,
October 1, 2009;
32(10):
1851 - 1856.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Holmes Jr, K. H. Monahan, and D. Packer
Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation: Clinical Spectrum and Interventional Considerations
J. Am. Coll. Cardiol. Intv.,
April 1, 2009;
2(4):
267 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al.
Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop
Circulation,
February 3, 2009;
119(4):
606 - 618.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Bejot, D. B. Salem, G. V. Osseby, G. Couvreur, J. Durier, C. Marie, Y. Cottin, T. Moreau, and M. Giroud
Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006
Neurology,
January 27, 2009;
72(4):
346 - 353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine,
January 1, 2009;
2(1):
med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y Bejot, M Caillier, D Ben Salem, G Couvreur, O Rouaud, G-V Osseby, J Durier, C Marie, T Moreau, and M Giroud
Ischaemic stroke subtypes and associated risk factors: a French population based study
J. Neurol. Neurosurg. Psychiatry,
December 1, 2008;
79(12):
1344 - 1348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Fatema, K. R. Bailey, G. W. Petty, I. Meissner, M. Osranek, A. A. Alsaileek, B. K. Khandheria, T. S. Tsang, and J. B. Seward
Increased Left Atrial Volume Index: Potent Biomarker for First-Ever Ischemic Stroke
Mayo Clin. Proc.,
October 1, 2008;
83(10):
1107 - 1114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S.M. Tsang, M. E. Barnes, Y. Miyasaka, S. S. Cha, K. R. Bailey, G. C. Verzosa, J. B. Seward, and B. J. Gersh
Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years
Eur. Heart J.,
September 2, 2008;
29(18):
2227 - 2233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Y H Lip and C J Boos
Antithrombotic treatment in atrial fibrillation
Postgrad. Med. J.,
May 1, 2008;
84(991):
252 - 258.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray
A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland
Heart,
May 1, 2007;
93(5):
606 - 612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, K. R. Bailey, S. S. Cha, B. J. Gersh, J. B. Seward, and T. S.M. Tsang
Mortality Trends in Patients Diagnosed With First Atrial Fibrillation: A 21-Year Community-Based Study
J. Am. Coll. Cardiol.,
March 6, 2007;
49(9):
986 - 992.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Y.H. Lip, L. Frison, M. Grind, and on behalf of the SPORTIF Investigators
Effect of hypertension on anticoagulated patients with atrial fibrillation
Eur. Heart J.,
March 2, 2007;
28(6):
752 - 759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Mykytsey, J. L. Bauman, M. Razminia, T. Zheutlin, T. Wang, M. Saleem, S. Leal, and R. F. Kehoe
Observations on the Safety and Effectiveness of Dofetilide in Patients With Paroxysmal Atrial Fibrillation and Normal Left Ventricular Function
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2007;
12(1):
36 - 43.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. L. Flaherty, B. Kissela, D. Woo, D. Kleindorfer, K. Alwell, P. Sekar, C. J. Moomaw, M. Haverbusch, and J. P. Broderick
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
Neurology,
January 9, 2007;
68(2):
116 - 121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Williams
The Year in Hypertension
J. Am. Coll. Cardiol.,
October 17, 2006;
48(8):
1698 - 1711.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
651 - 745.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
854 - 906.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
e149 - e246.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
e257 - e354.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation,
August 15, 2006;
114(7):
700 - 752.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J.,
August 2, 2006;
27(16):
1979 - 2030.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. P. Abhayaratna, J. B. Seward, and T. S.M. Tsang
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
Circulation,
July 11, 2006;
114(2):
119 - 125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyasaka, M. E. Barnes, B. J. Gersh, S. S. Cha, K. R. Bailey, W. Abhayaratna, J. B. Seward, T. Iwasaka, and T. S.M. Tsang
Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades
Eur. Heart J.,
April 2, 2006;
27(8):
936 - 941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Y H Lip and C J Boos
Antithrombotic treatment in atrial fibrillation
Heart,
February 1, 2006;
92(2):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Boos, R. A. Anderson, and G. Y.H. Lip
Is atrial fibrillation an inflammatory disorder?
Eur. Heart J.,
January 2, 2006;
27(2):
136 - 149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. M. Sundt and B. J. Gersh
Making Sense of the Maze: Which Patients With Atrial Fibrillation Will Benefit?
JAMA,
November 9, 2005;
294(18):
2357 - 2359.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Marini, F. De Santis, S. Sacco, T. Russo, L. Olivieri, R. Totaro, and A. Carolei
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study
Stroke,
June 1, 2005;
36(6):
1115 - 1119.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Gersh, T. S.M. Tsang, M. E. Barnes, and J. B. Seward
The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factors
Eur. Heart J. Suppl.,
May 1, 2005;
7(suppl_C):
C5 - C11.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Wachtell, B. Hornestam, M. Lehto, D. J. Slotwiner, E. Gerdts, M. H. Olsen, P. Aurup, B. Dahlof, H. Ibsen, S. Julius, et al.
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study
J. Am. Coll. Cardiol.,
March 1, 2005;
45(5):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Wachtell, M. Lehto, E. Gerdts, M. H. Olsen, B. Hornestam, B. Dahlof, H. Ibsen, S. Julius, S. E. Kjeldsen, L. H. Lindholm, et al.
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study
J. Am. Coll. Cardiol.,
March 1, 2005;
45(5):
712 - 719.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. E. Hagens, K. M. Vermeulen, E. M. TenVergert, D. J. Van Veldhuisen, H. A. Bosker, O. Kamp, J. H. Kingma, J. G.P. Tijssen, H. J.G.M. Crijns, I. C. Van Gelder, et al.
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation -- results from the RAte Control versus Electrical cardioversion (RACE) study
Eur. Heart J.,
September 1, 2004;
25(17):
1542 - 1549.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abidov, R. Hachamovitch, A. Rozanski, S. W. Hayes, M. M. Santos, M. G. Sciammarella, I. Cohen, J. Gerlach, J. D. Friedman, G. Germano, et al.
Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography
J. Am. Coll. Cardiol.,
September 1, 2004;
44(5):
1062 - 1070.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-M. Cha, M. M. Redfield, W.-K. Shen, and B. J. Gersh
Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle
Circulation,
June 15, 2004;
109(23):
2839 - 2843.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y. W. Lew, and S. Tsimikas
Highlights of the year in JACC 2003
J. Am. Coll. Cardiol.,
December 17, 2003;
42(12):
2156 - 2166.
[Full Text]
[PDF]
|
|
|
|
